DTC Act of 2025

The DTC Act of 2025 requires pharmaceutical companies to include a drug's list price (for a 30-day supply) in direct-to-consumer television and digital ads for prescription drugs covered by Medicare or Medicaid. It applies to ads for drugs costing $35 or more per 30-day supply, exempting lower-cost medications. Manufacturers must disclose the list price clearly by July 1, 2026, with penalties of up to $100,000 per violation for noncompliance. The bill aims to provide consumers with upfront pricing information to help them compare costs before filling prescriptions, particularly affecting drugs commonly advertised to Medicare beneficiaries.